RecruitingNot Applicable

National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns

France2,500 participantsStarted 2010-12-13

Plain-language summary

After 7 then 13 valent pneumococcal conjugate vaccine (PCV) implementation in France in children, we will evaluate the impact of this vaccination on invasive pneumococcal disease (IPD). We will describe the clinical characteristics of IPD, pneumococcus serotyping, underlying conditions and vaccination status.

Who can participate

Age range1 Day – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Isolate of Streptococcus pneumoniae from at least one blood culture, or pleural fluid, or joint fluid, or cerebrospinal fluid or other normally sterile body site, or if there is a positive blood polymerase chain reaction (PCR). Exclusion Criteria: * Pneumococcal strain not transmetted to National Reference Center for Pneumococci or to Regional Pneumococci Observatory

What they're measuring

Severity of invasive pneumococcal disease

Timeframe: before hospital discharge

Trial details

NCT IDNCT04664556

SponsorAssociation Clinique Thérapeutique Infantile du val de Marne

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-01-01

Contact for this trial

Levy Corinne

1 48 85 04 04 corinne.levy@activ-france.fr

View on ClinicalTrials.gov More Pneumococcal Infections trials